Evidence map›Paper›PMID 35724262›Full record

ArticleRevista da Escola de Enfermagem da U S P2022

Tools for the investigation of adverse events: scoping review.

Lucas Rodrigo Garcia de Mello, Barbara Pompeu Christovam, Ana Paula Amorim Moreira, Erica Brandão de Moraes, Graciele Oroski Paes, Cassiana Gil Prates

Abstract readScoping Review
In one paragraph

Article in Revista da Escola de Enfermagem da U S P, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lucas Rodrigo Garcia de MelloUniversidade Federal Fluminense, Escola de Enfermagem Aurora Afonso Costa, Niterói, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0002-4833-606X
Barbara Pompeu ChristovamUniversidade Federal Fluminense, Escola de Enfermagem Aurora Afonso Costa, Niterói, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0002-9135-8379
Ana Paula Amorim MoreiraUniversidade Federal Fluminense, Escola de Enfermagem Aurora Afonso Costa, Niterói, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0003-1047-0658
Erica Brandão de MoraesUniversidade Federal Fluminense, Escola de Enfermagem Aurora Afonso Costa, Niterói, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0003-3052-158X
Graciele Oroski PaesUniversidade Federal Rio de Janeiro, Escola de Enfermagem Anna Nery, Rio de Janeiro, RJ, Brazil.ORCID http://orcid.org/0000-0001-8814-5770
Cassiana Gil PratesHospital Ernesto Dornelles, Serviço de Epidemiologia e Gerenciamento de Riscos, Porto Alegre, RS, Brazil.ORCID http://orcid.org/0000-0001-6077-8584

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo map, in the literature, the risk management tools aimed at investigating health adverse events.

methodScoping review according to the Joanna Brigss Institute, with acronym PCC (Population: hospitalized patients, Concept: tools for the investigation of adverse events, and Context: health institutions) carried out in MEDLINE (OVID), EMBASE, LILACS, Scopus, CINAHL, and gray literature.

resultsThe search totaled 825 scientific productions, 31 of which met the objective of the study, which consisted of 27 scientific articles and 4 expert consensus. It was possible to carry out a synthesis of the necessary steps for the investigation of adverse events and use of the tools according to the extent of damage.

conclusionThe practice of investigating adverse events should be guided by a thorough understanding of contributing factors, a fair culture, and the involvement of senior leadership.

Identifiers

PMID35724262
PMCPMC10114091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.